JESSICA MEIR

Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology LOS ANGELES, CA NPI 1891986808

General Payments — all program years on this page

$2,038.51

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 80
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $200.23 across 11 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $187.1210
Education $13.111

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
EISAI INC. $51.653
NOVARTIS PHARMACEUTICALS CORPORATION $49.213
Ceribell, Inc. $25.401
Lundbeck LLC $23.411
ABBVIE INC. $21.061
Teva Pharmaceuticals USA, Inc. $16.391
Amgen Inc. $13.111

By program year

Program yearAmountRecords
2018 $447.2718
2019 $778.8520
2020 $91.106
2021 $377.7217
2022 $15.231
2023 $128.117
2024 $200.2311

Records — PY2024 (11)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087126228 Novartis Pharmaceuticals Corporation $16.46 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087126230 Novartis Pharmaceuticals Corporation $15.81 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087126232 Novartis Pharmaceuticals Corporation $16.94 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105017898 ABBVIE INC. $21.06 01/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110752648 Eisai Inc. $17.83 04/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110752650 Eisai Inc. $17.45 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110752652 Eisai Inc. $16.37 01/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111649672 Amgen Inc. $13.11 04/23/2024 Education Undisputed 01/23/2026 View at CMS
1145945632 Lundbeck LLC $23.41 02/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151580203 Teva Pharmaceuticals USA, Inc. $16.39 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153954558 Ceribell, Inc. $25.40 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.